.9

We hereby consent to the inclusion in this Annual Report on Form 40-F for the year ended April 30, 2022 of ImmunoPrecise Antibodies, Ltd. of our report dated July 28, 2022, with respect to the consolidated financial statements included as .2 in this Annual Report. We also consent to the incorporation by reference of our report in the Registration Statements of ImmunoPrecise Antibodies Ltd. on Form F-10 (File No. 333-249957) and on Form S-8 (File No. 333-256730). We also consent to the use of our name as it appears under the caption “Interests of Experts”, which appears in the Annual Information Form, included as to the Annual Report of ImmunoPrecise Antibodies, Ltd., on Form 40-F.

/s/ GRANT THORNTON LLP

Minneapolis, Minnesota

July 28, 2022